Alembic Pharma names Sudhakar Pandiyan as Head -Technical Operations (Sterile & Oncology)

Published On 2024-09-19 07:00 GMT   |   Update On 2024-09-19 07:00 GMT
Advertisement

Vadodara: Alembic Pharma has announced that Sudhakar Pandiyan has been appointed as Head - Technical Operations (Sterile & Oncology), designated as Senior Management Personnel of the Company w.e.f. 16th September, 2024.

Sudhakar Pandiyan has done Master of Science in Microbiology from MS University, Tamil Nadu and Bachelor of Science in microbiology, University of Madras. Sudhakar Pandiyan has around 20 years of progressive experience in sterile products manufacturing and quality operations. He has been associated with Caplin Steriles Ltd., Mylan Laboratories Limited, Caplin Point Laboratories Limited, Strides Arcolab Limited and Novartis Vaccines and Diagnostics. Over the last 2.5 years, he has been associated as a consultant with various pharmaceuticals companies.

Advertisement

Read also: USFDA approves Alembic Pharma Albendazole Tablets

Alembic Pharmaceuticals Limited, a vertically integrated research and development pharmaceutical company. Headquartered in India, Alembic is a publicly listed company that manufactures and markets generic pharmaceutical products all over the world. Alembic's state of the art research and manufacturing facilities are approved by regulatory authorities of many developed countries including the USFDA.

Read also: Alembic Pharma wins USFDA okay for Betamethasone Valerate Foam

Tags:    

Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.

NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.

Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .

Similar News